V. T. Pal’cHun

V. T. Pal’cHun

Auto-generated profile, based on publicly available information

V. T. Pal’cHun

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VPV. T. Pal’cHun
V. T. Pal’cHun
AKA. I. Kriukov
A. I. Kriukov
AGAlexander Gurov
Alexander Gurov
TDT. K. Dubovaya
T. K. Dubovaya
AEAleksandr Ermolaev
Aleksandr Ermolaev
Introduction. According to different authors, 4 to 40% of the child and adult population suffer from chronic tonsillitis (СT), with many authors noting an increase in the number of cases and no tendency to decrease the frequency of this pathology.Objective. To optimize diagnostics and treatment tactic of taking patients with chronic tonsillitis (CT) using our own clinical and laboratory data and morphological data as well as literature data.Materials and methods. Аt the first stage of work, 166 patients were examined. They were divided into 4 categories (experimental groups) depending on clinical CT classification according to B.S. Preobrazhensky and V.T. Palchun. We also formed a group of patients who did not have CT symptoms. All patients underwent tonsillectomy or tonsillotomy. All tissue samples of palatine tonsils we got were investigated using immunohistochemical markers and default histological colorings. At the second stage, the dynamics of complaints, clinical symptoms and laboratory parameters were assessed in 247 patients diagnosed with CT Toxic-Allergic Form I (CT TAF I) before conservative treatment and 3 months after conservative treatment. Patients were divided into 3 groups depending on the conservative treatment regimen: a course of flushing the lacunae of the tonsils; antibiotic therapy with a retard form of clarithromycin; complex treatment combining the first two options.Results. Тhe chronic inflammatory process in the palatine tonsils changes their cytoarchitectonics. At the same time, there is a direct correlation between the presence and severity of changes with the clinical classification of chemotherapy according to B.S. Preobrazhensky and V.T. Palchun.Conclusion. With CT TAF II, the palatine tonsil not only loses its importance as an organ of the immune system, but also becomes a hotbed of infection in the body, which can cause severe complications. Only tonsillectomy can effectively protect the patient from these complications. At the stage of CT TAF I, the formation of metatansillar complications occurs. Patients with this form of CT require special attention, and correctly conducted conservative therapy can protect patients from local and general complications of CT. A variant of such conservative therapy that gives a lasting effect is complex therapy with washing the lacunae of the palatine tonsils with an antiseptic solution and simultaneous antibiotic therapy with 14-membered macrolides that can accumulate in the lymphadenoid tissue.

1 January 2022 in Russian Bulletin of Otorhinolaryngology
Verified
Journal Article
Closed access
VPV.T. Palchun
V.T. Palchun
AKA.I. Kryukov
A.I. Kryukov
AGAlexander Gurov
Alexander Gurov
AKA.A. Kelemetov
A.A. Kelemetov
Alexandra ErmolaevaAlexandra Ermolaeva
Alexandra Ermolaeva
DMD.L. Muratov
D.L. Muratov
На данный момент во всем мире существует большое количество разнообразных методик хирургического лечения хронического тонзиллита, в частности классическая тонзиллэктомия, криохирургическое воздействие на небные миндалины, шейверная тонзиллэктомия, монополярная и биполярная тонзиллэктомия, тонзиллэктомия при помощи ультразвукового скальпеля, биполярная диссекция с использованием режущего инструментария, лазерная тонзиллэктомия, коблация. В данной статье проанализированы существующие методы, описана принципиальная техника их выполнения, а также рассмотрены их преимущества и недостатки. С учетом обилия различных хирургических подходов к лечению хронического тонзиллита возрастает необходимость в проведении исследований, направленных на сравнительное изучение их клинической и микробиологической эффективности, включая послеоперационный период.

20 April 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. I. Kriukov
A. I. Kriukov
VPV. T. Pal’cHun
V. T. Pal’cHun
AGAlexander Gurov
Alexander Gurov
TDT. K. Dubovaya
T. K. Dubovaya
AEAleksandr Ermolaev
Aleksandr Ermolaev
ZMZ. V. Murzakhanova
Z. V. Murzakhanova
Introduction. The high incidence of chronic tonsillitis (CT), as well as the high risk of complications, make research in this area very relevant. The ambiguity of approaches to conservative therapy determines the need to search for new, reasonably effective, chemotherapy regimens.Objective. To carry out a comparative characteristic of various options for conservative therapy of chronic tonsillitis of toxicallergic form (TAF) I degree (CT TAF I).Materials and methods. The study included patients with CT TAF I according to the classification of B.S. Preobrazhensky and V.T. Palchun. The patients were divided into three clinical groups, depending on the therapy. Patients of the first group underwent a course of washing the lacunae of the tonsils with 1% dioxidine solution. Patients of the second group were prescribed antibiotic therapy with a retard form of clarithromycin. Patients of the third group underwent complex treatment – washing the lacunae of the palatine tonsils and simultaneously taking antibiotic therapy. The effectiveness of treatment was assessed by comparing the dynamics of changes in complaints, pharyngoscopic symptoms of CT, regional lymph nodes, and laboratory parameters.Results. Complex conservative therapy of CT TAF I provides early relief of patients’ complaints (in 93.2% of patients on the 7th day from the start of treatment), the maximum decrease in the severity of local CT symptoms (up to 1 point on the VAS at the end of treatment, with the exception of the Zak sign — 1.4 points) and the greatest positive dynamics of laboratory parameters.Conclusions. The analysis showed that for patients with CT TAF I, complex therapy, including a course of washing the lacunae of the palatine tonsils with 1% dioxidine solution and simultaneous administration of antibacterial therapy with a retard form of clarithromycin, is the most optimal therapeutic tactic that allows to achieve an earlier and stable reduction in the severity of symptoms HT, patient complaints, as well as the normalization of laboratory parameters.

14 November 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VPV. T. Pal’cHun
V. T. Pal’cHun
AGA. L. Guseva
A. L. Guseva
YLYu. V. Levina
Yu. V. Levina
MDM. L. Derbeneva
M. L. Derbeneva
The clinical picture of allergic rhinitis includes sneezing, nasal discharge, impaired nasal breathing, and itching of the nose and roof of mouth. Depending on the duration of symptoms, allergic rhinitis is divided into intermittent and persistent forms, and depending on the severity of symptoms, it can be mild, moderate, and severe. Treatment for allergic rhinitis includes elimination of allergic contacts, allergen-specific immunotherapy, and pharmacotherapy. The choice of a treatment regimen is determined by the severity of symptoms, age of a patient and presence of concomitant diseases. The work is aimed to review the most common pharmaceuticals to treat allergic rhinitis. Saline solutions are used as monotherapy when symptoms are mild, or before use of other topical drugs to clean mucous membranes before their application. Intranasal glucocorticosteroids can be used as monotherapy, if symptoms have different levels of severity, and supplemented with other drugs, in case they are not efficient. Intranasal glucocorticosteroids do not have a systemic effect due to minimal bioavailability. The patients with moderate/severe allergic rhinitis are recommended to use them jointly with second generation antihstamines, intranasal cromones, intranasal antihistamines and leukotriene receptor antagonists. The significant side effect of antihistamines, especially of the first generation, are sedative effects on the central nervous system. The side effects of leukotriene receptor antagonists are neuropsychological disorders. Intranasal cromones have a high safety profile, which makes them popular in paediatric practice. However, the dosage regimen up to 3–4 times a day reduces patient adherence to treatment. Decongestants are not indicated as monotherapy for allergic rhinitis but can be used in combination with other drugs in short courses, taking into account the possible side effects.